Nevro Past Earnings Performance
Past criteria checks 0/6
Nevro has been growing earnings at an average annual rate of 11.2%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 2.9% per year.
Key information
11.2%
Earnings growth rate
14.6%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 2.9% |
| Return on equity | -25.3% |
| Net Margin | -16.5% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Nevro makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 419 | -69 | 314 | 52 |
| 30 Jun 24 | 426 | -77 | 327 | 55 |
| 31 Mar 24 | 431 | -83 | 337 | 54 |
| 31 Dec 23 | 425 | -92 | 335 | 54 |
| 30 Sep 23 | 423 | -102 | 335 | 56 |
| 30 Jun 23 | 419 | 3 | 332 | 56 |
| 31 Mar 23 | 415 | 2 | 329 | 55 |
| 31 Dec 22 | 406 | 3 | 322 | 53 |
| 30 Sep 22 | 395 | -8 | 324 | 52 |
| 30 Jun 22 | 388 | -140 | 325 | 49 |
| 31 Mar 22 | 386 | -136 | 315 | 49 |
| 31 Dec 21 | 387 | -131 | 309 | 48 |
| 30 Sep 21 | 394 | -108 | 294 | 47 |
| 30 Jun 21 | 409 | -68 | 283 | 46 |
| 31 Mar 21 | 363 | -88 | 269 | 45 |
| 31 Dec 20 | 362 | -83 | 267 | 46 |
| 30 Sep 20 | 367 | -90 | 276 | 51 |
| 30 Jun 20 | 358 | -98 | 280 | 53 |
| 31 Mar 20 | 396 | -84 | 296 | 57 |
| 31 Dec 19 | 390 | -104 | 306 | 59 |
| 30 Sep 19 | 384 | -100 | 301 | 56 |
| 30 Jun 19 | 379 | -93 | 292 | 55 |
| 31 Mar 19 | 382 | -76 | 281 | 52 |
| 31 Dec 18 | 387 | -49 | 267 | 48 |
| 30 Sep 18 | 377 | -44 | 239 | 45 |
| 30 Jun 18 | 364 | -39 | 228 | 42 |
| 31 Mar 18 | 346 | -40 | 218 | 40 |
| 31 Dec 17 | 327 | -37 | 220 | 38 |
| 30 Sep 17 | 299 | -42 | 202 | 39 |
| 30 Jun 17 | 278 | -40 | 184 | 37 |
| 31 Mar 17 | 255 | -37 | 165 | 36 |
| 31 Dec 16 | 229 | -32 | 142 | 34 |
| 30 Sep 16 | 191 | -36 | 126 | 28 |
| 30 Jun 16 | 146 | -52 | 112 | 26 |
| 31 Mar 16 | 102 | -63 | 98 | 23 |
| 31 Dec 15 | 70 | -67 | 82 | 21 |
| 30 Sep 15 | 46 | -62 | 64 | 20 |
| 30 Jun 15 | 39 | -50 | 49 | 20 |
| 31 Mar 15 | 36 | -38 | 37 | 20 |
| 31 Dec 14 | 33 | -31 | 30 | 20 |
| 30 Sep 14 | 29 | -29 | 26 | 20 |
| 30 Jun 14 | 27 | -26 | 24 | 19 |
| 31 Mar 14 | 25 | -26 | 21 | 19 |
| 31 Dec 13 | 24 | -26 | 19 | 20 |
Quality Earnings: 1N7 is currently unprofitable.
Growing Profit Margin: 1N7 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1N7 is unprofitable, but has reduced losses over the past 5 years at a rate of 11.2% per year.
Accelerating Growth: Unable to compare 1N7's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 1N7 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Return on Equity
High ROE: 1N7 has a negative Return on Equity (-25.33%), as it is currently unprofitable.